Pregabalin as add-on treatment to botulinum toxin in idiopathic hemifacial spasm

Neurology

Volumn 66, Issue 11, 2006, Pages 1781-

  Urban, Peter P ^a,b  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; PREGABALIN; VOLTAGE GATED CALCIUM CHANNEL;

ADD ON THERAPY; ADULT; ARTICLE; CASE REPORT; DOSE TIME EFFECT RELATION; DRUG EFFICACY; FEMALE; HEMIFACIAL SPASM; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ANTI-DYSKINESIA AGENTS; ANTICONVULSANTS; BOTULINUM TOXINS; DRUG COMBINATIONS; FEMALE; GAMMA-AMINOBUTYRIC ACID; HEMIFACIAL SPASM; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 33745648764     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000218209.59228.67     Document Type: Article

References (7)

1. Tan NC, Chan LL, Tan EK. Hemifacial spasm and involuntary movements. Q J Med 2002;95:493-500.
2. Kondo A. Follow-up results of microvascular decompression in trigeminal neuralgia and hemifacial spasm. Neurosurgery 1997;40:46-51.
3. Brin MF, Danisi F, Blitzer A. Blepharospasm, oromandibular dystonia, Meige's syndrome and hemifacial spasm. In: Moore P, Naumann M, eds. Handbook of botulinum toxin treatment. Oxford: Blackwell, 2003;119-141.
4. Kessler KR, Benecke R. The EDB test - a clinical test for the detection of antibodies to botulinum toxin type A. Mov Disord 1997;12:95-99.
5. Daniele O, Caravaglio G, Marchini C, Mucchiut M, Capus L, Natale E. Gabapentin in the treatment of hemifacial spasm. Acta Neurol Scand 2001;104:110-112.
6. Cole RL, Lechner SM, Williams ME, et al. Differential distribution of voltage-gated calcium channel alpha-2 delta (α2δ) subunit mRNA-containing cells in the rat central nervous system and the dorsal root ganglia. J Comp Neurol 2005;491:246-269.
7. Ben-Menachem E. Pregabalin pharmacology and its relevance to clinical practice. Epilepsia 2004;45 Suppl 6:13-18.